RESUMO
ObjectiveTo investigate the clinical efficacy of spreading moxibustion on tne Du meridian in treating allergic rhinitis. MethodOne hundred andonepatients meeting the inclusion criteria were allocated, using a random number table, to treatment and control groups. The control group took loratadine tablets and the treatment group received spreading moxibustion on tne Du meridian. Both groups were treated for three consecutive months.ResultThe total efficacy rate was 90.6% in the treatment group, which was higher than 83.3% in the control group. There were statistically significant post-treatment differences in the incidences of sneezing (20.2±9.8 and 22.8±9.5) and runny nose (22.6±9.4 and 26.1±10.7) between the treatment and control groups (P<0.01). There were also statistically significant post-treatment differences in the severities of nasal obstruction, itching and mucosal edema between the treatment and control groups (P<0.01). Meanwhile, There were statistically significant pre-/post-treatment differences in the scores in the treatment and control groups (P<0.01).ConclusionSpreading moxibustion therapy can more effectively improve the clinical symptoms of allergic rhinitis. It has the advantage over Western medication.